Log in to save to my catalogue

Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from...

Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3076764514

Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial

About this item

Full title

Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial

Publisher

United States: Elsevier Inc

Journal title

The American journal of cardiology, 2024-09, Vol.226, p.83-96

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

•In a post hoc analysis of a recent Japanese clinical trial, more than half of the patients with acute coronary syndromes received anticoagulation with unfractionated heparin after percutaneous coronary intervention (PCI). This was especially true for patients with ST-segment elevation myocardial infarction or intraprocedural adverse angiographic f...

Alternative Titles

Full title

Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3076764514

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3076764514

Other Identifiers

ISSN

0002-9149,1879-1913

E-ISSN

1879-1913

DOI

10.1016/j.amjcard.2024.07.002

How to access this item